← prelander teardowns

Side by side · CS-P1 top-5 ranking

Our page on the right, word for word. The kept page on the left, part by part, described in our words, with a link that opens their live page at those lines (their text and pictures are not copied here). The plan under each of their parts was written from the teardown, before our page: where our page went another way, the right column is what stands. Mark each part and leave a note. It saves as you go, and a mark on a part of ours shows on every comparison of that page.
Compare CS-P1 with
Theirs

Rovina · top-N ranking

Astaxanthin works and most bottles fail to deliver it; a short formulation test (dose, source, delivery) picks out the one that does.

1,547 words · brand named 15% down the page · 3 buttons, the first at 34% · house chief 5/10 · craft chief REVISE

Open their live page ↗ · the full teardown

Ours

The 5 Best Astaxanthin Supplements For Kidneys, Brain, Eyes & Joints

CS-P1 · 2,395 words · live since 2026-09-14, your Copy Studio rounds 1 and 2 applied; 11 proposed changes wait on your verdict

Open our live page ↗ · comment line by line in the Copy Studio

The order, at a glance

Each bar is one page from first word to last. Width is the share of the page's words. Click a block to jump to that part.

Theirs
astaxanthin named · 3%brand named · 94%
Ours
astaxanthin named · 3%brand named · 15%first button · 28%
OpeningHer storyWhat she triedThe turnThe cause and the reason whyProofThe productResultsDoubts and limitsThe askThe close

What we took from this page

  • Agree the rules before naming a brand: criteria first (entry 13), cards second, the same rules back as ticks at the end (entries 41-42). The reader's early yes becomes the verdict.
  • Plant a yardstick in the winner's card and spend it in the rival cards (entry 19 feeding 24, 28, 37). For us the yardstick is the routine and the verified lab test (b9, c3), because our guarantee is 30 days.
  • The failed-purchase replay in three beats (entry 10), followed at once by the turn that clears the ingredient and blames the bottle (entry 11).
  • Concede before marking down: every rival card opens with what it gets right (entries 23, 27, 36).
  • One number the reader can check inside a rival card (entry 29).
  • A lineup picture of all five packs above the lead (entry 7).
  • Winner first, with a button at the foot of its card a third of the way down (entries 15-22). CS-P1 already does this.
  • A rule-of-thumb close as a short chant of specifications (entry 46).
  • A recap section between the last rival and the close for the reader who skipped the cards (entries 40-43). CS-P1 lacks it.

What we left on it

  • The testing claim in the headline: no test is shown (entry 3).
  • FABRICATIONS: the anonymous team with a stock-style portrait (entry 5), letter grades with no method (entry 15), the unnamed pharmacist (entry 16), the ranking system named only in fine print (entries 26, 30, 39), the generic publication (entry 48), the 50-plus sample (entry 40).
  • The expose card (entries 31-35): fraud accusations against a named rival with no evidence shown. CL-13 and legal risk.
  • Unsupported rival defects: soy, 30-day returns, weaker testing (entries 24, 28, 37). Our own reading of two of these rivals' sites found different guarantee terms.
  • The 90-against-30-day argument: our guarantee is 30 days (CL-09).
  • Carrier-oil and absorption superiority (entries 13, 16): banned for us (b8).
  • Drawbacks that are compliments (entry 17).
  • Counts that disagree and a stale date (entries 5, 12, 13, 40).
  • Closed toggles over the criteria explanations (entry 13).
  • Buttons that ask only for a look, with no noun, price or guarantee (entries 22, 45).

Part by part · 15 paired · 13 theirs only · 4 ours only

I am
What the page admitstheirs at 0% of the wordstheirs only
Theirs, in our words
#2at 0%●●○○○cta · p · 5 words

A small advertiser-disclosure link in the masthead and an all-capitals label above the headline state that the page is paid advertising.

Why it works. Meet native-network and FTC labelling before any claim is made, in type too small to compete with the headline. candor

Why it sits here, and how it is written

It stands before the headline because ad platforms check the first screen. Placed there, it is read before the reader has met a single claim to doubt, and it is never repeated near a button.

Two labels, five words in all, set in grey. In the local capture the masthead beside them carries a magazine-style name and logo, so the page says advertisement and dresses as a publication in the same glance.

Planned for ours, before we wrote: kept the move. CS-P1 carries its ad disclosure only in the footer; the byline's advertorial tag was removed on 2026-09-15. House law L-07 asks that the editorial chrome never contradict the disclosure strip. Whether a strip moves to the top is a call for David and the external claims reviewer. No Truth-Gate claim is involved.

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

The headlinetheirs at 0% of the words · ours at 0%
Theirs, in our words
#3at 1%●●●●○h1 · 11 words

A first-person tester says five well-known astaxanthin products were tried, and promises to say which things count when choosing one.

Why it works. Select the reader who already wants astaxanthin and offer a shortcut: somebody else did the comparing. earned-authoritycuriosity-gapspecificity

Why it sits here, and how it is written

The reader arrives from an ad already sold on the ingredient, so the headline skips the case for astaxanthin and sells a filter for choosing a bottle. It needs the belief that bottles differ, and it sets up the factors and the list.

Eleven plain words and one dash. The 'I' is the only voice on the page that claims hands-on work, and nothing below shows a trial: no method, no dates, no photographs, no results. The promise is paid with a reading of labels.

Planned for ours, before we wrote: kept the move. CS-P1's H1 already promises a five-product ranking and, unlike this one, names the four organs (kidneys, brain, eyes, joints) as CL-04 asks. It speaks as an editor, and its honest verb is that the five were bought and their labels read. Keep ours. Do not borrow the testing claim, because no trial was run. r10r6b3b4

See these lines on their page ↗
Ours, word for word
The 5 Best Astaxanthin Supplements For Kidneys, Brain, Eyes & Joints
The line under the headlinetheirs at 1% of the words · ours at 0%
Theirs, in our words
#4at 2%●●●○○p · 19 words

The deck says the writer studied the research and used several brands, and that what follows are the factors dividing astaxanthin that does something from a costly dud.

Why it works. Turn the headline's curiosity into a money worry and name the form of the answer: a short set of factors. loss-aversioncontrastopen-loop

Why it sits here, and how it is written

It sits directly under the headline and above the byline, so the fear of a wasted purchase is in place before the reader asks who is speaking. It makes the lead's replay of a failed bottle feel like confirmation.

One sentence of nineteen words. Its last two words are the only colour; the opening clause about studying the science is vague and could sit on any supplement page.

Planned for ours, before we wrote: kept the move. CS-P1's subhead does this job with a count (five softgels, three tests, one winner) and its intro asks whether the bottle in the cabinet does anything. It has the move. Our evidence that bottles differ is c1: about 64% of unverified astaxanthin products fail third-party potency testing. c1

See these lines on their page ↗
Ours, word for word

Five softgels, three tests, one winner for kidneys, brain, eyes and joints.

The picturetheirs at 3% of the words · ours at 1%in a different place on their page
Theirs, in our words
#7at 5%●●●○○img · 0 words

A wide banner with no alt text. In the local capture it lines up the five ranked packs on a pale background, the seller's bag first on the left, in the same order as the ranking.

Why it works. Show the whole field at once and let the reader spot a pack already seen in ads or sitting at home. identificationanchoring

Why it sits here, and how it is written

It stands above the lead, so the reader knows five real brands are coming before any argument starts. Seeing a familiar bottle makes the coming criticism of it personal.

The picture gives the result away: left to right is first to fifth. Real trade dress does the credibility work that the missing test photographs cannot do.

Planned for ours, before we wrote: kept the move. CS-P1's hero is our own bag alone, captioned as the top pick, and each rival still appears only inside its card. It lacks one picture of all five together. A lineup built from the rival stills already on CS-P1 would do this job; alt text is customer copy.

Open on their page ↗
Ours, word for word
Picture caption: Our #1 pick: one 12 mg softgel a day, 30 to a bag, every batch third-party lab tested.
Who is speakingtheirs at 2% of the words · ours at 2%
Theirs, in our words
#5at 4%●●○○○2× p · 13 words

The byline credits an unnamed editorial research team. The date line shows an update in June 2025 and a reading time of four minutes.

Why it works. Give the page the furniture of journalism (byline, date, reading time) so the ranking reads as reporting. borrowed-authorityease

Why it sits here, and how it is written

After the promise the reader asks who is talking. The answer comes as a format, not as a person, and the short reading time lowers the cost of continuing just as the body begins.

FABRICATION: the headline says 'I', the byline says a team, and no person, credential or outlet is given. In the capture a stock-style portrait of a smiling woman sits beside the team credit. The date is a year older than the 2026 in the page title.

Planned for ours, before we wrote: rewritten to our claims. CS-P1 already fills this slot and goes further: a named editor with a generated portrait, sixteen years of experience, a nine-minute read and a press strip of four magazine names. CL-14 forbids an invented authority figure, so the persona and the press names need David's confirmation or a plain editorial credit. This competitor attacks a rival for an unverifiable endorser in entry 32; the same attack could be turned on any invented byline.

See these lines on their page ↗
Ours, word for word

By Ruth Calloway · Health Editor · 16 years covering supplements for readers over 50 Updated September 14, 2026 · 9 min read

As Featured In

  • Prevention
  • AARP
  • Reader's Digest
  • Men's Health
What she already triedtheirs at 3% of the words · ours at 3%
Theirs, in our words
#8at 6%●●●●○h3 · 8 words

A section heading states that the usual experience with astaxanthin is to notice nothing.

Why it works. Name the reader's private disappointment as the common case, so that reading on feels like getting an explanation. mirroringcuriosity-gapconsensus

Why it sits here, and how it is written

These are the first words of the body. The deck said duds exist; the heading now says most buyers got one, which makes the reader's own flat result normal and blameless before any product is named.

Eight words, no product, no promise. The claim about most buyers is unsupported, and the heading works anyway because it describes the reader.

Planned for ours, before we wrote: kept the move. CS-P1 opens on the multivitamin that never gets to the cell (p3, r3, r5) and has no line for the reader who tried astaxanthin and felt nothing. For our reader in their 60s and 70s that is right: p7 says most of the market has never heard of astaxanthin. A retargeting variant could open on the failed bottle. p3r3r5p7

See these lines on their page ↗
Ours, word for word

If you are over 50, you have probably been told to take a multivitamin. Vitamin C. Vitamin E. Most of it never gets where it is needed. It moves through the bloodstream and leaves as waste, and the inside of the cell, where the damage happens, stays open. Astaxanthin is different. It is fat-soluble, so it settles into the cell membrane instead of passing through. That is why it has been studied for the kidneys, the eyes, the brain and the joints. It carries about 6,000 times the antioxidant power of vitamin C.

Proposed change 2 · Intro: her own cabinet waits on your verdict

The kept rankings open by replaying the reader's own mornings in short beats, before any science. Ours states it as a fact about the category.

If you are over 50, you have probably been told to take a multivitamin. Vitamin C. Vitamin E. You have taken them every morning for years. Most of it never gets where it is needed.

Proof: the researchtheirs at 4% of the wordstheirs only
Theirs, in our words
#9at 7%●●●○○p · 28 words

The first paragraph grants the ingredient its reputation: a very strong natural antioxidant with more than 70 peer-reviewed studies in five areas, from skin and eyes to joints, energy and recovery.

Why it works. Agree with what the reader already believes, so the coming criticism lands on products and not on the ingredient. borrowed-authorityconsensuscommitment

Why it sits here, and how it is written

It is placed before the disappointment so the reader first says yes to the science. If the failed bottle came first, the reader could decide the ingredient is hype and leave.

Two sentences and a list of five benefit areas. The study count comes without a single named study, and the five areas are broad enough for any reader to find one.

Planned for ours, before we wrote: our proof in its place. CS-P1's intro carries the reputation in one line (about 6,000 times vitamin C, m3) and names four organs. It does not state a study count. Ours is r14 (60+ clinical studies), and r15 lets us call it nature's most powerful antioxidant. r14r15m3

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

What she already triedtheirs at 5% of the wordstheirs only
Theirs, in our words
#10at 8%●●●●●p · 15 words

Three short beats replay the reader's own history: bought it, took it for months, felt little.

Why it works. Make the reader feel seen, and put a price on the problem: months and money already spent. mirroringidentificationloss-aversion

Why it sits here, and how it is written

It follows the praise of the science so the gap between promise and result is felt at full width. It has to come before the explanation, because an explanation is wanted only once the letdown is admitted.

The best rhythm on the page: three fragments, the last trailing off on an ellipsis. Second person, no adjectives, fifteen words.

Planned for ours, before we wrote: kept the move. CS-P1 has no replay of a failed purchase. Our equivalent for the senior reader is the cabinet of vitamins taken for years with nothing to show (r3, r23), which CS-P1's intro states as a fact and does not act out. Written as the reader's own history in short beats it would land harder. Never the collagen-plateau story (p1). r3r23

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

The causetheirs at 6% of the wordstheirs only
Theirs, in our words
#11at 8%●●●●●p · 13 words

The turn: the ingredient is cleared, and the blame moves to products that fail to deliver it.

Why it works. Absolve the reader and the ingredient in one line, and point at the bottle as the culprit. vindicationcontrastcommon-enemy

Why it sits here, and how it is written

It comes straight after the letdown, while the reader is asking why. It keeps the wish for astaxanthin alive and makes brand choice the only open question, which is the question a ranking answers.

It opens on a throat-clearing frame, then gives two short sentences; the capture shows them in bold. The second sentence is soft: it says some products underdeliver and does not say how.

Planned for ours, before we wrote: rewritten to our claims. CS-P1 has the fact (c1, in the method box) without the turn. Our culprit is the unverified bottle: about 64% fail third-party potency tests (c1), and a tested badge is a claim while verified lab results are proof (c3; David's 2026-09-15 wording for CS-P1 is lab tested, with no QR-code line). Their delivery argument rests on carrier oil, which is banned for us (b8). c1c3

See these lines on their page ↗
Ours, word for word

Nothing on our page today.

Proposed change 3 · Intro: the turn waits on your verdict

The kept pages turn from the cabinet to the reason in one step: the nutrient is sound, the bottle is the risk. That makes buying again reasonable. Our potency figure sits lower, in the method box.

Astaxanthin does reach the cell. But first the full dose has to be in the softgel. When outside labs test unverified astaxanthin products, about 64% fail on potency. So we bought the five products people over 50 actually buy and read every label.

The turntheirs at 7% of the wordstheirs only
Theirs, in our words
#12at 9%●●●●○p · 24 words

The narrator reports a finding from the research: three factors decide whether a supplement does its job or simply leaves the body unused.

Why it works. Promise a short, countable test and hand the reader the role of judge. earned-authorityspecificityopen-loop

Why it sits here, and how it is written

It bridges the culprit to the criteria. The reader now believes bottles differ and wants to know how to tell; the number three makes the answer feel learnable before the list begins.

One sentence in the first person, with a dash before the consequence. The research is referred to as vaguely as in the deck. The count of three is contradicted by the very next heading.

Planned for ours, before we wrote: kept the move. CS-P1 has this: its subhead and intro promise three tests. Its method box then lists five things, the same slip in counting this page makes between entries 12 and 13. Settle on one number.

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

How the list was rankedtheirs at 9% of the words · ours at 7%
Theirs, in our words
#13at 10%●●●●○h2 · 3× h3 · h4 · 2× cta · 29 words

A heading announces five critical factors. Only three follow, as numbered toggle titles: the 12 mg dose as the clinical standard, a natural microalgae source for bioavailability, and oil-based delivery over dry powder.

Why it works. Set the yardstick before any product is shown, so the ranking looks like the result of rules. reason-whyspecificitycommitment

Why it sits here, and how it is written

Criteria come before the cards so the reader agrees to the rules while no brand is at stake. Each rule is one the seller's product meets, so agreeing here is agreeing to the winner in advance.

The heading says five, the lead said three, three are shown. The explanations sit behind closed toggles (the capture shows plus signs), so a reader who does not tap gets titles only. One title switches to capitals halfway through.

Planned for ours, before we wrote: rewritten to our claims. CS-P1 has the method box, open and explained, which is better than closed toggles. Ours rest on b7 (12 mg against the 4 to 6 mg brands), c4 (natural microalgae, the form in the positive human studies), c1 and c3 (lab testing) and b9 (one softgel a day). Their third factor, oil against powder, is a carrier argument and stays out (b8). b7c4c1c3b9

See these lines on their page ↗
#14at 13%●●●○○h2 · p · 24 words

The list's title, then one sentence of method: the narrator examined five popular products and scored them on four things, the three rules plus value.

Why it works. Open the ranking and state who judged and on what. earned-authorityspecificity

Why it sits here, and how it is written

It is the last line before the first card. A fourth yardstick, value, is added only now, after the three formulation rules were agreed; price enters as a tiebreaker the seller expects to win.

The verb has weakened from the headline's testing to looking. Eighteen flat words. Nothing on how the five were chosen or how a grade is worked out.

Planned for ours, before we wrote: kept the move. CS-P1 has this and is more honest about it: the five are the ones people over 50 buy, the labels were read, and the price is worked out per day from each brand's own site. It also says which test every rival passes and that it therefore did not decide the order (L-04).

See these lines on their page ↗
Ours, word for word

So we bought the five products people over 50 actually buy and read every label. We ranked them on three things that decide whether the bottle in your cabinet does anything. Is there a clinical dose of 12 mg from the studies in one softgel? Does it actually work? How much does it cost?

How we ranked them
The 5 things that decided this list
  • Is the full 12 mg in one softgel? — 12 mg a day is the dose the human trials used. One product on this list needs four softgels a day to get there.
  • Is it third-party lab tested? — About 64% of unverified astaxanthin products fail third-party potency tests. “Third-party tested” on a label is a claim. Verified lab results are proof.
  • Is it natural astaxanthin from microalgae? — The form the positive human studies used. All five pass, so it did not decide the ranking.
  • What does a day cost? — Worked out per day at the price on each brand’s own site, not per bottle.
  • Will you still be taking it on day 30? — One softgel with a meal is a routine that survives. Four a day, twice a day, is not.
Proposed change 4 · How we ranked them: the rule waits on your verdict

The strongest ranking you kept states its rule above the cards: qualify first, then rank. It lets a rival pass a test and still place lower, without the list contradicting itself.

One line under the five things: “To make this list, a product had to be natural astaxanthin from microalgae. All five are. The order comes from three scores: 12 mg in one softgel, third-party lab tested, and cost per day.”

A product cardtheirs at 12% of the words · ours at 15%
Theirs, in our words
#15at 15%●●●●○h2 · h3 · 2× p · 9 words

Card one: the seller's own 12 mg product, credited to its maker, under the top letter grade.

Why it works. Crown the house product first, in the visual language of a school report. anchoringcontrast

Why it sits here, and how it is written

The winner leads the list. A scanner who reads one card reads this one, and every later card is then read against it. The cost is that the result is known at once, on the seller's own domain.

FABRICATION: a letter grade with no scoring method anywhere on the page. Four short lines and no claim yet.

Planned for ours, before we wrote: kept the move. CS-P1 also puts our product first, with three scored bars in place of a letter, and gives itself 7.5 on cost per day, which a letter cannot show. Keep the bars. Two things to fix on CS-P1: the rival scores do not fall in rank order (the second-ranked card has the lowest numbers), and one rival's body names a rank it does not hold. b7c3

See these lines on their page ↗
#16at 17%●●●●○h1 · 9× p · 85 words

Nine plus points, each a bold label with a gloss: dose, source, coconut-oil softgel, third-party testing, clean label, traceable sourcing, the 90-day guarantee, a pharmacist's recommendation, and the lowest daily cost at 33 cents.

Why it works. Bury doubt under volume and cover every criterion, then add commercial points the rivals will later lose on. specificityreason-whysocial-proofrisk-reversalanchoring

Why it sits here, and how it is written

The longest list on the page sits in the first card, so every rival's shorter list looks thin beside it. The first three lines repeat the three agreed rules in order, so the card opens by passing the test.

Label, dash, gloss, nine times: steady and scannable, and by the sixth line it drones. FABRICATION: the pharmacist is unnamed, and batch testing is claimed with no certificate shown. The daily price appears with no pack price to check it against.

Planned for ours, before we wrote: rewritten to our claims. CS-P1's winner card has five plus points of one line each, and that restraint reads better. Ours: the full 12 mg in one softgel (b7, b9), every batch third-party lab tested (c3), natural microalgae from closed bioreactors with no heavy metals (c4, c5), the 30-Day Money-Back Guarantee, free shipping. We cannot claim the lowest cost per day: our best tier is 60 cents. No carrier-oil line (b8). b7b9c3c4c5

See these lines on their page ↗
#17at 22%●●●○○h1 · 2× p · 11 words

Two minus points for the winner: it is sold only online, and it often runs out because so many people order it.

Why it works. Look even-handed while turning both drawbacks into selling points. candorscarcitysocial-proof

Why it sits here, and how it is written

A card with no drawbacks would read as an advert, so two are supplied right after the nine plus points. The second plants the idea of stock running out, which the runner-up's card relies on in entry 25.

Ten words in total. Neither is a real cost to the buyer, and the second is a boast. A reader who notices loses trust in every other minus point on the page.

Planned for ours, before we wrote: kept the move. CS-P1 has the better version, under a heading that replaces the word cons: it is a supplement and not a treatment, it is sold only on the official site (r29), and the multi-bag prices are launch pricing. The first of those is a real limit. Keep ours, and add no sold-out line unless stock is truly short. r29

See these lines on their page ↗
#18at 24%●●●●○h3 · 2× p · 45 words

The verdict opens: this is the only product on the list to meet every requirement, and its 12 mg natural, oil-based softgel is said to match what the studies used and not a cheaper cut.

Why it works. Convert the list of plus points into one sentence the reader can repeat. exclusivityborrowed-authoritycontrast

Why it sits here, and how it is written

After the lists the reader needs a conclusion before the longer argument. The claim to be the only one is made here, ahead of the rival cards that are supposed to prove it.

The voice has moved from 'I' to 'our list'. Two sentences; the second ends on a two-adjective jab at cheaper products, the first sign of heat in the card.

Planned for ours, before we wrote: rewritten to our claims. CS-P1 has this as the callout that explains why our product took the top spot: the only one passing all three tests at once. It rests on b7, c3 and the daily price. c4 lets us say that the natural, microalgae-derived form is the one used in the positive human studies. b7c3c4

See these lines on their page ↗
#19at 26%●●●●●2× p · 60 words

Two further paragraphs: a claim of full transparency (test certificates, traceable sourcing, clean label), then the assertion that it works, with tissue saturation at four to six weeks and reported gains in energy, recovery, joints, skin and cell function.

Why it works. Plant the time-to-effect figure that the rest of the page uses as a weapon. reason-whyspecificityfuture-pacingnew-mechanism

Why it sits here, and how it is written

The four-to-six-week figure has to appear in the winner's card, before any rival, because every later attack on a 30-day return (entries 24, 25, 28, 37) depends on the reader already holding it.

The strongest structural sentence on the page is dressed as a passing fact. The saturation term is unexplained jargon. The benefit list is five abstractions in a row. The certificates are mentioned and never shown or linked.

Planned for ours, before we wrote: rewritten to our claims. CS-P1 has a week-by-week timeline, placed after the cards, where it cannot serve as a yardstick. Ours: energy in weeks 1 to 2 (r7), eye strain relief in 14 to 28 days (b6), gut in weeks 4 to 8 (r8), kidney labs re-drawn at 8 to 12 weeks (r10). Their use of the figure to condemn 30-day returns cuts against our 30-Day Money-Back Guarantee, so our yardsticks are the routine and the verified lab test (b9, c3). r7b6r8r10b9c3

See these lines on their page ↗
#20at 29%●●●●○h3 · 3× p · 92 words

The card's summary casts rivals as corner-cutters (small doses, synthetic raw material, dry capsules) and this product as treating oxidative stress at its origin with the three rules met, at 33 cents a day, filler-free, with 90 days to judge.

Why it works. Restate the case as us against the corner-cutters and close the card on the guarantee. common-enemycontrastreason-whyrisk-reversal

Why it sits here, and how it is written

A scanner reads the top and the bottom of a card. This summary repeats the three rules, adds the price and ends on the guarantee, so the button below it follows a risk-free thought.

Three paragraphs; the middle one is four parallel clauses with a bracket after each, and reads like a spec sheet spoken aloud. The guarantee is given a reason (the time needed to judge), which is the best sentence here. The phrase about root causes is large for an antioxidant.

Planned for ours, before we wrote: rewritten to our claims. CS-P1's winner body does this in two paragraphs. Ours: the 4 to 6 mg brands against the full 12 mg (b7), synthetic against natural (r16, c4), and the guarantee under its one name, the 30-Day Money-Back Guarantee. Our daily price is higher than theirs, so the summary closes on the verified lab results (c3) and not on price. b7r16c4c3

See these lines on their page ↗
Ours, word for word
#1 · our card

Editor's Choice

1 Best

Astaxanthin Softgels (resealable bag)

CellScience™ Astaxanthin 12mg — The Cell Shield

One softgel a day is the full 12 mg. Verified third-party lab results. Natural microalgae, grown in closed bioreactors. 30-day money-back, and you keep the bag.

Picture caption: One softgel with a meal: 12 mg of natural astaxanthin, 30 to a bag, every batch third-party lab tested.

12 mg in one softgel

10.0 / 10

Third-party lab tested

Cost per day

7.5 / 10

Why it took the top spot: It is the only product here that passes all three tests at once. The full 12 mg is in one softgel. Every batch is third-party lab tested, and the results are verified. And a month costs less than any rival except the two bargain bottles that ask you to take their word on the testing.

The astaxanthin is natural, from microalgae grown in closed bioreactors, so nothing from the outside world gets in. Because it is fat-soluble, it is absorbed with the fat in your meal instead of being flushed as kidney waste. That is why it is studied for the kidneys, the brain, the eyes and the joints. One softgel is less for your kidneys to handle than most multivitamins.

✓ Why readers are switching to this
  • The full 12 mg in one softgel — the dose the human trials used
  • Every batch third-party lab tested, results verified
  • Natural microalgae astaxanthin from closed bioreactors, no heavy metals
  • One softgel with a meal — the routine you keep
  • 30-day money-back guarantee, keep the bag; free shipping on every order
✗ Worth knowing
  • It is a daily supplement, not a treatment — keep your doctor and your labs
  • Sold only on the official site, never on Amazon or eBay
  • The 3-bag and 5-bag prices are launch pricing, and the bag says so
What the page admitstheirs at 32% of the wordstheirs only
Theirs, in our words
#21at 33%●○○○○fine · 25 words

Fine print under the card: results reflect users' own experience, may not be typical, and the product site has more.

Why it works. Legal cover for the efficacy sentences above it.

Why it sits here, and how it is written

It comes after the claims and before the button, in the smallest type, where it protects the seller without slowing the reader.

Stock wording, 25 words. It speaks of users' experiences although the card quoted none.

Planned for ours, before we wrote: store chrome. CS-P1 carries its supplement disclaimer and ad disclosure once, in the footer. No fine print is needed under each card.

See these lines on their page ↗
Ours, word for word

Nothing on our page today.

Proposed change 9 · Every card: where the facts came from waits on your verdict

The kept pages print the basis of each card in small type under it. Ours has the dates in the builder's notes and not on the page. A dated source is true, it is fair to the rival, and it protects the page with ad reviewers.

Small print under each rival card: “Label, serving and price read on the brand's own product page, September 14, 2026.” Under our card: “Label, serving and price read on the CellScience product page, September 28, 2026.” Both dates are fixed text. The date on our card is the day the page is rebuilt.

The buttontheirs at 34% of the words · ours at 28%
Theirs, in our words
#22at 34%●●●○○h2 · 5 words

The first link to the product: an invitation to find out more about the brand, with an arrow.

Why it works. Give the convinced scanner a way out to the product page a third of the way down. commitmentease

Why it sits here, and how it is written

It closes the winner's card at 34% of the page. Before it there was nothing to click; after it the reader is inside the rival cards. The wording asks for a look and not a purchase, which suits a reader with four cards still unread.

Four words and an arrow, styled as a heading. No price, no guarantee, no noun for what waits on the other side.

Planned for ours, before we wrote: our offer in its place. CS-P1 has a full block after the winner card: the noun, the per-bag price from the 5-bag tier, free shipping and the 30-Day Money-Back Guarantee. Ours is stronger. CL-16 asks for one button vocabulary per funnel; CS-P1 currently uses three labels.

See these lines on their page ↗
Ours, word for word
Try The Cell Shield With A 30-Day Money-Back Guarantee

From $17.99 a bag on the 5-bag supply · free shipping · 30-day money-back guarantee

Try The Cell Shield Risk-Free 30-day money-back guarantee
🔒 Secure checkout · One-time purchase, no subscription · Free US shipping
A product cardtheirs at 34% of the words · ours at 30%
Theirs, in our words
#23at 35%●●●○○2× h2 · 7× p · h1 · 37 words

Card two: Sports Research, grade B-plus. Five plus points grant it the 12 mg dose, a natural source, a coconut-oil softgel, third-party testing and non-GMO sourcing.

Why it works. Concede that the runner-up passes all three rules, so the ranking looks fair. candorcontrast

Why it sits here, and how it is written

Second place has to be a credible rival that passes the agreed test. Having granted that, the page must mark it down on grounds the criteria section never named.

The glosses shrink to two or three words each, against full phrases in the winner's card. The thinness is itself the markdown.

Planned for ours, before we wrote: kept the move. CS-P1 does this for every rival and with checked facts: each rival's format, count, serving and price were read on its own product page on 2026-09-14 (CL-13, L-04). Keep ours.

See these lines on their page ↗
#24at 39%●●●○○h1 · 4× p · 38 words

Four minus points: it is said to contain soy, to offer no batch-level verification, to allow only 30 days for returns, and to test less strictly.

Why it works. Open a gap between first and second on ground the criteria never covered. contrastloss-aversion

Why it sits here, and how it is written

The rival passed the three rules, so new yardsticks appear only now: allergen, batch proof, return window. The return window counts as a flaw only because entry 19 set the four-to-six-week clock.

UNSUPPORTED: no label, link or test is shown for any of the four. The last point compares testing standards without naming either standard. Our own reading of this rival's site on 2026-09-14 found a guarantee badge with no stated term.

Planned for ours, before we wrote: rewritten to our claims. CS-P1 marks this rival down on one checkable point: a tested badge with no batch report to open (our answer is c3), plus a guarantee that states no term. It also credits the rival as the cheapest per day. That is the fair version (CL-13). Never claim an ingredient or a test result we did not read on the rival's own page. c3

See these lines on their page ↗
#25at 42%●●●○○2× h3 · 3× p · 92 words

The verdict grants the basics, says soy and missing batch proof cost it first place, and argues a 30-day return cannot test a product needing four to six weeks. The summary: a fallback if the winner is sold out.

Why it works. Rank the rival as the spare and never the choice. contrastreason-whyscarcitycandor

Why it sits here, and how it is written

Recommending the rival only when the winner is unavailable does two things at this point: it sounds generous, and it reminds the reader of the stock warning from entry 17.

Three paragraphs that repeat the minus points in sentence form. The one fresh idea is the fallback line. The register turns written and hedged where the lead was spoken.

Planned for ours, before we wrote: rewritten to our claims. CS-P1 gives each rival a one-line verdict tag and a two-paragraph body, which is tighter. We cannot use the return-window argument, because ours is 30 days. Our gap against this rival is verified batch results (c3). c3

See these lines on their page ↗
Ours, word for word
#2 · rival card

2 Rank

Astaxanthin Softgels (bag)

Rovina Astaxanthin 12mg

The one you have seen in ads. Natural astaxanthin in coconut oil, with a catch on the label: four softgels a day to reach 12 mg.

12 mg in one softgel

5.0 / 10

Third-party lab tested

6.0 / 10

Cost per day

4.0 / 10

Rovina gets the source right. Its astaxanthin comes from the same microalgae ours does, and it sits in organic coconut oil. The bag is resealable and the guarantee is a generous 90 days.

Then read the directions. Two softgels in the morning and two in the evening. That is four a day to reach the 12 mg serving, and a bag of 60 lasts 15 days. The brand says every batch is third-party tested; the results are available on request rather than posted. At the price we saw, a month is two bags.

✓ Pros
  • Natural astaxanthin from microalgae, in organic coconut oil
  • 90-day money-back guarantee
  • Made in a GMP-certified, FDA-registered facility
✗ Cons
  • Four softgels a day, morning and evening, to reach 12 mg
  • A 60-softgel bag is a 15-day supply
  • Batch test results on request, not posted

$$$$ · four softgels a day The right source, the wrong routine

Proposed change 1 · Rival cards: the order waits on your verdict

On the rankings you kept, a rival's place matches its scores. Ours puts the lowest-scoring product second, and BioAstin's text says it earns the second spot while it sits third. A reader who checks the bars sees the list disagree with itself.

Order the four rivals by our own three scores: #2 Sports Research · #3 BioAstin · #4 Dr. Mercola · #5 Rovina. BioAstin's sentence becomes two: “BioAstin has been on shelves longer than anyone here. It earns third place on the label alone.”

Proposed change 8 · Rovina card: who it suits waits on your verdict

Same move: the card ends on who should still buy it.

Last line of the card: “Who it suits: the buyer who wants the 90-day guarantee, and does not mind four softgels a day.”

What the page admitstheirs at 45% of the wordstheirs only
Theirs, in our words
#26at 46%●○○○○fine · 22 words

Fine print credits the results to a named ranking system and says they may not reflect typical outcomes.

Why it works. Legal cover. It also implies that a scoring method exists. borrowed-authority

Why it sits here, and how it is written

It sits under the rival's card, where a grade has just been given, so the grade seems to come from a system.

FABRICATION or leftover: the Smarter Reviews system it names is described nowhere on the page. The name belongs to a known review-site template, which suggests the page was cloned and the line never edited.

Planned for ours, before we wrote: left out. CS-P1 shows its three tests and the numbers on every card, so it needs no named system. Do not invent one.

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

A product cardtheirs at 46% of the words · ours at 39%
Theirs, in our words
#27at 47%●●○○○2× h2 · h3 · 5× p · h1 · 35 words

Card three: NOW Foods, grade C-plus. Four plus points: natural source, an oil softgel with MCT oil, a lower price, and wide availability in shops.

Why it works. Present the budget choice fairly before disqualifying it on dose. candorcontrast

Why it sits here, and how it is written

Third place is where a rival first fails one of the three agreed rules. The ranking needed two passes before a fail, so the rules look as if they discriminate.

Short glosses again. Price and shop availability are credited as virtues here and nowhere claimed for the winner.

Planned for ours, before we wrote: kept the move. CS-P1 has no rival under 12 mg: all five are 12 mg products (CL-13, same species). The underdosed brand appears in our copy only as a class, the 4 to 6 mg brands (b7), and not as a ranked card. b7

See these lines on their page ↗
#28at 51%●●●○○h1 · 5× p · 41 words

Five minus points: a 10 mg dose, generic ingredients, ordinary quality control, a 30-day return, and soy with other fillers.

Why it works. Fail the rival on the first rule and pile on. contrastspecificityloss-aversion

Why it sits here, and how it is written

The dose shortfall leads the list because it is the only point tied to the agreed criteria. The rest repeat the secondary yardsticks introduced in the card before.

Only the first point can be checked from a label (the lineup picture shows 10 mg on the bottle). The two points about ingredients and quality control are judgments with nothing behind them.

Planned for ours, before we wrote: rewritten to our claims. Our dose argument is b7: 12 mg against the 4 to 6 mg brands, stated as a spec and in the method box. CS-P1 already has it and turns it into a point about routine: the full 12 mg in one softgel, where one rival needs four a day (b9). b7b9

See these lines on their page ↗
#29at 54%●●●○○2× h3 · 3× p · 83 words

The verdict calls it a budget choice, adequate for casual use and disqualified for anyone wanting the full dose. The summary works the shortfall out as 17 percent under 12 mg and urges paying for an effective dose.

Why it works. Turn a 2 mg gap into a reason to spend more. specificitycontrastloss-aversionidentification

Why it sits here, and how it is written

The page splits readers into casual and serious here, halfway down, so that staying with a cheaper bottle becomes a statement about the reader. It prepares the closing line about wasted money in entry 46.

The percentage is the sharpest detail in any rival card: arithmetic the reader can check. The investing verb is used twice in one sentence.

Planned for ours, before we wrote: rewritten to our claims. The arithmetic move transfers: state a gap as a number the reader can verify. Ours on CS-P1 is four softgels a day against one (b9) and a bag that lasts 15 days, both read from the rival's page. Never the human-capital framing (p8). b9b7

See these lines on their page ↗
Ours, word for word
#3 · rival card

3 Rank

Astaxanthin Gelcaps (bottle)

BioAstin Hawaiian Astaxanthin 12 mg

The old name in the category, grown in Hawaii. The full 12 mg in one gelcap, and no batch results anywhere on the page.

12 mg in one softgel

9.5 / 10

Third-party lab tested

3.0 / 10

Cost per day

8.5 / 10

BioAstin has been on shelves longer than anyone here, and it earns the second spot on the label alone. One gelcap is the full 12 mg, taken with food, from microalgae grown on the Kona coast. Bought by the 120, it is one of the cheapest days on this list.

What it does not give you is proof. We could not find a third-party test or a batch report on the product page. The gelcap is bovine gelatin in safflower oil. The guarantee is 45 days, and the company may ask for the unused portion back. When we checked, both bottle sizes were out of stock on its own site until October.

✓ Pros
  • One gelcap a day is the full 12 mg
  • Grown in Hawaii from microalgae; sold almost everywhere
  • One of the lowest costs per day when you buy the 120-count
✗ Cons
  • No third-party test or batch report on the product page
  • Bovine gelatin gelcap; the 45-day guarantee may ask for the product back
  • Out of stock on its own site until October when we checked

$ · one gelcap a day The name you know, without the paperwork

Proposed change 6 · BioAstin card: who it suits waits on your verdict

Same move: the card ends on who should still buy it.

Last line of the card: “Who it suits: the buyer who trusts the oldest name on this list, and buys the 120-count.”

What the page admitstheirs at 57% of the wordstheirs only
Theirs, in our words
#30at 58%●○○○○fine · 22 words

The same fine print as under card two, naming the ranking system again.

Why it works. Legal cover, cloned. borrowed-authority

Why it sits here, and how it is written

Same slot as in entry 26: under the grade, lending it a source.

Word for word the line from entry 26. A leftover from the template.

Planned for ours, before we wrote: left out. Nothing stands here on CS-P1.

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

A product cardtheirs at 58% of the words · ours at 49%
Theirs, in our words
#31at 59%●●●○○h2 · h3 · 4× p · h1 · 32 words

Card four: Clarity MD. The grade label is there with no letter captured. Three plus points grant the 12 mg dose and the oil softgel, and word the natural source as something the brand asserts.

Why it works. Grant the product its formula so the attack that follows can be about the company. candorcontrastopen-loop

Why it sits here, and how it is written

The page concedes the softgel first. That makes what comes next read as fairness, and it answers in advance the reader who thinks the rival's formula looks the same as the winner's.

The third plus point is hedged with two distancing words, the only hedged praise on the page. It signals the turn before the minus list starts.

Planned for ours, before we wrote: left out. CS-P1 ranks only comparable products and says nothing about a rival's conduct (CL-13). No card of this kind.

See these lines on their page ↗
#32at 63%●●●●●h1 · 7× p · 118 words

Seven accusations: an unverifiable doctor endorser, disease-treatment marketing with no product trials, illegal disease promises (dialysis, macular degeneration, fatty liver), invented reviews, evergreen countdown timers, testing claimed with no certificate or lab name, and a false country of origin.

Why it works. Discredit the direct-response rival whose ads the reader is most likely to have seen, and look like the category's watchdog. common-enemyspecificitycontrastpattern-interrupt

Why it sits here, and how it is written

It is fourth, past the halfway mark, where a list usually sags. Three polite cards have set a calm tone, so the change of register jolts the reader awake. It comes after the winner so the accusations define the winner by contrast.

The most specific writing on the page: a named persona, quoted promises, a list of tactics. One label is in capitals and one line has a typing error. UNSUPPORTED on this page: no screenshot, link or record backs any of the seven. The same store publishes kidney-angle advertorials (five are in this research set), so the stance is tactical.

Planned for ours, before we wrote: left out. Not transferable. CL-13 allows only fair, verified comparisons between comparable products, and an accusation of fraud is a legal risk. Our category-level substitute is c1 (about 64% of unverified products fail potency tests) and c2 (the Amazon leader stopped publishing its certificates), stated without naming a culprit. WARNING for our side: the disease promises listed here belong to the family our gate holds as r10 and r11, and CS-P1's final block ties the product to the reader's next labs. The external claims reviewer should see this card. c1c2

See these lines on their page ↗
#33at 70%●●●●○h3 · p · 90 words

A long verdict: a genuine ingredient proves nothing about the seller. The softgel may be fine; the operation is called a scam that takes over $2,000 a year by subscription. An analogy: a genuine watch from a fake shop.

Why it works. Give the reader a picture to remember the rival by, and a number for what it would cost. common-enemyloss-aversionspecificitycontrast

Why it sits here, and how it is written

After seven bullet accusations the reader needs a single idea. The analogy supplies it, and the yearly cost converts indignation into a money fear at the moment the reader might think the rival sells the same softgel.

The longest paragraph on the page and the only one with an image in it. The analogy is fresh and exact. The sentence before it stacks four accusations and a dash and runs long. The yearly figure comes with no arithmetic.

Planned for ours, before we wrote: left out. Not transferable (CL-13). The craft lesson transfers: one concrete picture after a list. CS-P1's rival bodies have plain facts and no picture; the nearest is the tested badge with no report to open.

See these lines on their page ↗
#34at 73%●●●○○h3 · p · 64 words

The summary tells the reader to avoid the brand completely and to buy from a company with reputable retail, real test results and no disease claims, with a special warning for anyone who has the conditions its ads mention.

Why it works. Issue a do-not-buy order, and describe the honest seller in terms meant to fit the page's own winner. common-enemycontrastloss-aversion

Why it sits here, and how it is written

The order to avoid comes last in the card, after the evidence, so it reads as a conclusion. The description of a trustworthy brand doubles as a checklist the reader will apply to the winner in the recap at entry 40.

61 words: a four-word order, then two long sentences, the second with a semicolon and a dash. The advice to buy through reputable retailers contradicts the winner's own card (sold only online), and the next card faults a rival for being sold at retail.

Planned for ours, before we wrote: left out. Not transferable (CL-13). What we can say in our own voice is already on CS-P1's list of things worth knowing: a supplement and not a treatment, keep your doctor and your labs.

See these lines on their page ↗
Ours, word for word
#4 · rival card

4 Rank

Astaxanthin Veggie Softgels (bottle)

Sports Research Astaxanthin 12mg

The best value here: 12 mg in one veggie softgel at the lowest price per day. It shows a tested badge, and no batch report.

12 mg in one softgel

9.5 / 10

Third-party lab tested

5.0 / 10

Cost per day

If price decided this list, Sports Research would win it. Sixty veggie softgels for under thirty dollars, each one the full 12 mg from Icelandic microalgae in organic coconut oil. Made in a cGMP facility in the United States. Two months for the price of one of some rivals.

Then look for the test. The page shows a “Third Party Tested” badge, and that is where it stops. There is no batch report to open and no lot number to check it against. The guarantee badge says “satisfaction” and does not say how long. For a supplement you will take for years, we wanted the paper.

✓ Pros
  • 12 mg in one veggie softgel, with organic coconut oil
  • The lowest cost per day on this list
  • Made in cGMP facilities in the United States
✗ Cons
  • A “tested” badge with no batch report you can open
  • The guarantee does not state a term on the product page
  • A bottle, so the softgels see light every time you open it

$ · one softgel a day The value pick, on trust

Proposed change 5 · Sports Research card: who it suits waits on your verdict

On the kept pages each rival card ends on who should still buy it. It reads as fair, and it lets the reader place herself.

Last line of the card: “Who it suits: the buyer who wants the lowest cost per day, and will take the testing on trust.”

A product cardtheirs at 80% of the words · ours at 59%
Theirs, in our words
#36at 77%●●●○○2× h2 · h3 · 4× p · h1 · 28 words

Card five: BioAstin by Nutrex Hawaii, grade D-plus. Three plus points: grown in Hawaii, an oil softgel, a well-known name.

Why it works. Put the category's heritage brand last. contrastpattern-interrupt

Why it sits here, and how it is written

The oldest name is placed at the bottom, under the brand the page called a scam. A reader who came in trusting the heritage brand meets it with the worst grade, which unsettles the default choice.

The order breaks the page's own logic: the card above says avoid entirely, yet it outranks this one, whose worst fault is price. The plus points are three-word glosses.

Planned for ours, before we wrote: kept the move. CS-P1 ranks the same brand third and treats it fairly: the full 12 mg in one gelcap, among the cheapest per day, no batch report on the product page. L-04 says the incumbent the buyer already owns stays as the foil. Keep ours.

See these lines on their page ↗
#37at 81%●●○○○h1 · 5× p · 38 words

Five minus points: a 30-day return, a 25-day supply that means frequent reorders, poor value, the chance of uneven storage and freshness in retail channels, and a steep daily cost.

Why it works. Mark down a product that passes all three rules, using price, pack size and the return window. contrastloss-aversion

Why it sits here, and how it is written

It is the last card, so the markdowns are the commercial ones the recap is about to praise in the winner: guarantee length and cost per day. The reader goes from this list straight into the winner's checklist.

Two of the five say the same thing about price. The formatting differs from the other cards (no bold labels, a bracketed aside), a sign it was written at another time. Retail availability was a plus in card three and is a minus here. UNSUPPORTED: our reading of this rival's site on 2026-09-14 found a 45-day guarantee.

Planned for ours, before we wrote: rewritten to our claims. CS-P1's markdowns on this rival are the checkable ones: no third-party test on the product page, a 45-day guarantee that may ask for the product back, out of stock when checked. Our answer is c3. c3

See these lines on their page ↗
#38at 84%●●○○○2× h3 · 2× p · 70 words

A flat product description, then a summary that grants dose and delivery and faults daily cost, bottle size and thin testing disclosure, against rivals said to give more for the money, longer refund windows and a more answerable seller.

Why it works. Close the list with a rival that is adequate and unexciting, so the winner's recap feels like relief. contrastcandor

Why it sits here, and how it is written

The mildest verdict is saved for last so the reader leaves the list on a shrug. The closing comparison names the three things the recap leads with: value, guarantee, accountability.

The verdict is a label read aloud, with no judgment in it. The summary has 42 words in two sentences; the second holds three faults and three comparatives, six items at once.

Planned for ours, before we wrote: kept the move. The move is to end the rivals on the commercial points that the closing section then claims for the winner. CS-P1 ends its rivals on a catalogue brand marked down on price and proof, then goes to the timeline. It has the structure.

See these lines on their page ↗
Ours, word for word
#5 · rival card

5 Rank

Astaxanthin Capsules (bottle)

Dr. Mercola Organic Astaxanthin 12 mg

A doctor’s catalogue brand with an organic claim on the label. The full 12 mg in one capsule, at a price that adds up over a year.

12 mg in one softgel

9.5 / 10

Third-party lab tested

3.0 / 10

Cost per day

6.0 / 10

Mercola ticks the first box cleanly: one capsule with a meal is the full 12 mg, and the label says organic. If you already order from the catalogue, it is an easy add.

The price is the story. Thirty capsules cost more than a month of any other product here except Rovina, and the 90-count does not close the gap by much. We found no third-party test or batch report on the product page, and no guarantee term stated beside the product.

✓ Pros
  • One capsule a day is the full 12 mg
  • An organic astaxanthin claim on the label
  • Easy to add to an existing catalogue order
✗ Cons
  • Among the highest costs per day on this list
  • No third-party test or batch report on the product page
  • No guarantee term stated beside the product

$$$ · one capsule a day Clean label, catalogue price

Proposed change 7 · Dr. Mercola card: who it suits waits on your verdict

Same move: the card ends on who should still buy it.

Last line of the card: “Who it suits: the buyer who already shops with Mercola.”

What the page admitstheirs at 89% of the wordstheirs only
Theirs, in our words
#39at 88%●○○○○fine · 22 words

The ranking-system fine print, a third time.

Why it works. Legal cover, cloned. borrowed-authority

Why it sits here, and how it is written

Same slot as entries 26 and 30.

Identical to entries 26 and 30. Three sightings of one leftover line.

Planned for ours, before we wrote: left out. Nothing stands here on CS-P1.

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

Why this onetheirs at 90% of the wordstheirs only
Theirs, in our words
#40at 89%●●●○○h2 · p · 19 words

A heading declares a clear winner by name. One sentence says more than 50 supplements were evaluated and a single brand met every factor.

Why it works. Announce the result a second time, with a larger sample behind it. exclusivityspecificityloop-closed

Why it sits here, and how it is written

It comes right after the fifth card, when the reader who read every card is ready for a conclusion and the reader who skipped needs one. The sample grows from five to over 50 at the moment of the verdict.

INCONSISTENT: the headline tested five, the list examined five, and the recap evaluated more than 50. The heading names the winner, so the suspense the next lines try to build is already spent.

Planned for ours, before we wrote: kept the move. CS-P1 has no recap between the last rival and the timeline; its final heading asks whether the reader is ready for the one that passed all three tests. A short recap would serve the reader who skipped the cards. Keep the count honest: five products, labels read.

See these lines on their page ↗
#41at 90%●●●●○4× p · 20 words

Four ticks restate the formulation rules, each with a bracketed comment: the 12 mg dose, the microalgae source, the oil softgel, and third-party testing.

Why it works. Compress the ranking into a checklist the reader can carry to any bottle. commitmentspecificityreason-why

Why it sits here, and how it is written

The rules the reader agreed to at the start return as ticks, all passed. Because the reader accepted them before any brand was named, the ticks feel like the reader's own verdict.

Two or three words each, then a bracket. The brackets carry the attitude; one says the dose is not up for negotiation.

Planned for ours, before we wrote: rewritten to our claims. CS-P1's proof bar (three short claims under the timeline) is the nearest thing; it is not framed as the tests coming back. Ours: the full 12 mg in one softgel (b7, b9), natural microalgae (c4), every batch third-party lab tested (c3). No tick for a delivery oil (b8). b7b9c4c3

See these lines on their page ↗
#42at 91%●●●○○3× p · 19 words

Three further ticks cover the commercial side: a clean label free of fillers and soy, the 90-day guarantee, and the 33-cent daily cost.

Why it works. Add the points on which the rivals were marked down, so the winner wins on those too. risk-reversalanchoringcontrast

Why it sits here, and how it is written

These come after the formulation ticks because they are the tiebreakers: three rivals passed the formulation rules, and none was granted all three of these.

The clean-label bracket ends on a slang insult for synthetic additives, a register the rest of the page does not use. The price tick is the third repeat of the same figure.

Planned for ours, before we wrote: our offer in its place. Ours: the 30-Day Money-Back Guarantee with the bag kept, free shipping, and from $17.99 a bag on the 5-bag tier (60 cents a day). r18 covers the badges (cGMP, made in USA, gluten-free, no stimulants). CS-P1 has these in the winner card and the proof bar. r18x4

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

The product is namedtheirs at 94% of the wordstheirs only
Theirs, in our words
#43at 92%●●○○○p · 4 words

A four-word line names the brand as the one that met everything.

Why it works. Land the name as the answer to the checklist. loop-closed

Why it sits here, and how it is written

It is held until after the seven ticks so the name arrives as a conclusion. The heading at entry 40 had already given it away.

Four words in a paragraph of their own. Good rhythm after a list, and wasted by the heading that named the winner nine lines earlier.

Planned for ours, before we wrote: kept the move. If CS-P1 adds a recap, its closing line names The Cell Shield, the full noun (CL-02). CS-P1's final heading already points at the product without the name.

See these lines on their page ↗
Ours, word for word

Nothing on our page today.

Proposed change 11 · Winner card: the picture waits on your verdict

The winner's picture is the product page's hero slide. It has six claims and a price banner set into the picture, so no copy gate reads them. One callout is the QR line you took out of this page on 2026-09-15, and the banner is a price line on a page where you removed the price paragraph. The two new story pages now show the plain pack for the same reason.

Replace the winner's picture with the plain pack (the bag on its cream ground, no words in the picture). The card's own text already carries the 12 mg, the lab testing and the guarantee. Alt text: “A bag of CellScience Astaxanthin 12 mg softgels”.

Why this onetheirs at 94% of the wordstheirs only
Theirs, in our words
#44at 93%●●○○○h2 · 3× p · 47 words

A short section claims that marketers chasing margin run most of the category, while people who understand cell biology run this brand and therefore made one that meets every rule.

Why it works. Give the winner a motive, since the ranking only gave it a score. common-enemycontrastreason-why

Why it sits here, and how it is written

After the checklist a reader may ask why one brand would do all this when others do not. The answer offered is character. It comes late because it would sound like advertising before the evidence.

UNSUPPORTED: no founder, scientist or team is named. Three sentences; the last borrows the cadence of a famous speech about choosing hard things. The first line is missing its full stop.

Planned for ours, before we wrote: rewritten to our claims. CS-P1 has no section on who makes the product. Our true version is practice and not character: every batch third-party lab tested (c3), grown in closed bioreactors (c5). r19 allows a longevity doctor's recommendation with a quote once David confirms the doctor (CL-14). c3c5r19

See these lines on their page ↗
Ours, word for word

Nothing on our page today.

Proposed change 10 · New: the short version, after the last rival waits on your verdict

The kept pages restate the standards between the last rival and the close, for the reader who skipped the cards, and end on a rule she can use on any bottle. Ours goes from the fifth card straight to the timeline.

Heading: “The short version of this ranking, for your kidneys, brain, eyes and joints”. Body: “Before you buy any astaxanthin softgel, ask three questions. Is the full 12 mg in one softgel? Is it third-party lab tested? What does a day cost? Our #1 pick, The Cell Shield, is the only product here to score 10 out of 10 on the first two. The Cell Shield costs from $0.60 a day on the 5-bag supply. Our rule of thumb: count the softgels it takes to reach 12 mg, then look for verified third-party lab results.”

The buttontheirs at 97% of the wordstheirs only
Theirs, in our words
#45at 95%●●○○○h2 · 5 words

The learn-more link again, in the same four words.

Why it works. Catch the reader at the end of the case for the brand. commitment

Why it sits here, and how it is written

It stands at 95%, after the motive section. The wording is still the soft one from the first card, although the reader has now read the whole case.

Identical to the first link. No escalation between a button at 34% and one at 95%.

Planned for ours, before we wrote: our offer in its place. CS-P1's closing block has a heading, a two-sentence reason and a button with the guarantee. Ours is stronger.

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

What happens, week by weekours at 67%ours only
Theirs, in our words

Nothing on their page does this job here.

Ours, word for word
The honest week-by-week timeline

Astaxanthin works on a clock, and no product on this list can rush it. The one thing that changes the clock is whether you are still taking it. Here is the map our #1 pick prints on its own page.

• Weeks 1–2: Most people feel steadier energy first, and less of the afternoon slump. • Weeks 2–4: Eye strain relief usually lands here. Small print gets easier. • Weeks 4–8: Bloating eases, and skin starts to firm up. • Weeks 8–12: The window when kidney labs are usually re-drawn.

Any product promising to fix this in a week is selling you the label. The cells take weeks of the full dose, every day. Which is why the routine matters more than the marketing.

The guaranteeours at 73%ours only
Theirs, in our words

Nothing on their page does this job here.

Ours, word for word

30 days risk-free, keep the bag 12 mg in one softgel Lab tested , every batch

Reader commentsours at 73%ours only
Theirs, in our words

Nothing on their page does this job here.

Ours, word for word
What readers who tried our #1 pick are saying

184 Comments Most relevant

Denise R.

My eye drops are still in the drawer. Three weeks in and I read the paper in the morning without them. I scanned the code on the bag first, which I had never been able to do with any supplement.

👍 212

Like · Reply · 3h

Harold P.

My last labs came back the same or slightly better. My doctor asked what changed. One softgel with breakfast. Four stars only because I wish it came in a 90-count.

❤️ 121

Like · Reply · 6h

Margaret L.

I had no idea most of my vitamins were being flushed. The explanation on the page made sense of ten years of buying bottles. The afternoons are different now.

👍 98

Like · Reply · 9h

Tom W.

First one I have finished a whole bag of. One with lunch. My knees are quieter on the stairs, and I like knowing the batch was tested.

👍 64

Like · Reply · 1d

Questions and answersours at 80%ours only
Theirs, in our words

Nothing on their page does this job here.

Ours, word for word
Frequently asked questions
How much do I take?

One softgel a day with a meal that has some fat in it — eggs, yogurt, olive oil, avocado. Astaxanthin is fat-soluble, so food helps your body absorb the full 12 mg.

Will it help my kidney numbers?

It works upstream of the numbers, on the stress inside the cells that do your kidneys’ filtering work. It is fat-soluble, so it settles into cell membranes instead of being processed as kidney waste. It is a supplement, not a treatment. Keep working with your doctor and keep getting your labs done.

When will I notice something?

Weeks 1–2: most people feel steadier energy first. Weeks 2–4: eye strain relief usually lands. Weeks 4–8: bloating eases and skin starts to firm up. Weeks 8–12: the window when kidney labs are usually re-drawn. Take it daily and give it the full 12 weeks.

Is it safe with my medications?

Astaxanthin is a natural carotenoid with a long safety record. It does not interfere with common blood-pressure, diabetes or water-pill medicines. If you take blood thinners, or have a diagnosed kidney condition, check with your doctor first.

What is the guarantee?

30 days, money-back. Take it daily for up to 30 days. If the energy has not lifted and the eyes and joints have not eased, email for a full refund and keep the bag. No restocking fee, no small print.

The closetheirs at 98% of the words · ours at 90%
Theirs, in our words
#46at 96%●●●●○h1 · 3× p · 30 words

The close gives a rule of thumb: anyone taking astaxanthin should take the effective dose. A four-item chant of specifications follows, and a last line dismisses anything short of it as money thrown away.

Why it works. Leave the reader with a rule of thumb that only a few bottles pass. loss-aversionspecificitycommitment

Why it sits here, and how it is written

These are the final words before the last button. They return to the money fear from the deck, so the page ends where it began, now with the reader holding the answer.

The best cadence after entry 10: a conditional sentence, four fragments, a verdict. The chant lists four items where the lead promised three. It sells the specification and not the brand.

Planned for ours, before we wrote: rewritten to our claims. CS-P1's close says the difference is the full 12 mg in one softgel, lab tested and shipped free, and that it shows on the next labs. The chant form would sharpen it: 12 mg, one softgel, natural microalgae, every batch lab tested (b7, b9, c4, c3). The next-labs promise should go to the claims reviewer (r10, r11). b7b9c4c3

See these lines on their page ↗
Ours, word for word
Ready to try the one that passed all three tests?

The Cell Shield puts the full 12 mg in one softgel, is third-party lab tested, and ships free from the maker. That is the whole difference, and it is the one that shows up on your next labs.

The buttontheirs at 100% of the words · ours at 92%
Theirs, in our words
#47at 98%●●●○○h2 · 7 words

The last button asks the reader to try the brand for 90 days without risk.

Why it works. Ask for the purchase, with the guarantee inside the button. risk-reversalease

Why it sits here, and how it is written

Only the final button names the guarantee. The two before it asked for a look; this one asks for a trial, after the close has made not acting feel like waste.

Six words and an arrow, with the first verb on any button that implies buying. Styled as a heading.

Planned for ours, before we wrote: our offer in its place. CS-P1's buttons carry the noun and the 30-Day Money-Back Guarantee (CL-09). Check before traffic: the buttons land on the PDP's Try Before You Buy box (ob=c), which BRAND.md describes with a monthly lane and $6.99 shipping, while the line under the button says one-time purchase and free shipping.

See these lines on their page ↗
Ours, word for word
Try The Cell Shield Risk-Free Free US shipping · 30-day money-back guarantee
One-time purchase · 30-day money-back guarantee · Free US shipping
sidebar card
Editor's Pick #1 pick for kidneys, brain, eyes and joints
CellScience™ Astaxanthin 12mg — The Cell Shield
  • The full 12 mg in one softgel
  • Third-party lab tested, every batch
  • Natural microalgae · no heavy metals
  • 30-day money-back · keep the bag

4.9 · 2,847 verified customers

Check The Cell Shield Availability 🔒 30-day guarantee · Free US shipping

What the page admitstheirs at 78% of the words · ours at 96%in a different place on their page
Theirs, in our words
#35at 76%●●○○○fine · 27 words

Fine print unique to this card: the verdict rests on a review of the rival's marketing, sales page and checkout flow, and makes no statement about what is inside its softgel.

Why it works. Limit legal exposure by moving the claim from the product to the advertising. candor

Why it sits here, and how it is written

It stands directly under the harshest card, where the risk of a defamation complaint is highest. It is the one fine-print line on the page that was written for this page.

27 words, precise, lawyerly. It quietly concedes the softgel may be fine, which the card's own opening already granted.

Planned for ours, before we wrote: left out. No such card on our page, so no such line.

See these lines on their page ↗
Ours, word for word

Ad Disclosure: This article has ads. The Healthy Aging Review may earn a fee when you buy through links on this page. Results may vary. These statements have not been evaluated by the FDA. Products aren’t intended to diagnose, treat, cure, or prevent any disease. CellScience Astaxanthin is a dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. If you take blood thinners, have a diagnosed kidney condition, are pregnant, nursing or on medication, check with your doctor firs